In a stunning twist that has sent shockwaves through the WNBA and the growing Canadian basketball scene, star guard Marina Mabrey has reportedly failed her physical examination with the Toronto Tempo, just hours after the expansion franchise announced it was on the verge of signing the high-scoring veteran.
The Tempo, preparing for its inaugural season in the WNBA’s expansion to Canada, made waves earlier this week when it leaked plans to acquire the 29-year-old Mabrey, a two-time All-Star known for her elite shooting and playoff heroics with the Connecticut Sun and Chicago Sky. Sources close to the negotiations described the potential deal as a “game-changing” move to bring instant credibility to the new franchise.
However, optimism quickly turned to disappointment when Mabrey’s medical evaluation revealed undisclosed concerns regarding her left knee, an issue that had quietly lingered since last season. According to a league insider, the results showed “structural irregularities” that raised red flags for the Tempo’s medical staff, forcing the organization to pause the signing indefinitely.
“Marina is an incredible talent, and we were thrilled at the possibility of bringing her to Toronto,” a Tempo spokesperson said in a brief statement. “Player health remains our top priority. We are evaluating all options moving forward.”
Mabrey, who averaged 15.4 points, 4.8 assists, and 38% from three-point range last season, has not yet commented publicly. Her agent declined to provide details, citing privacy around medical matters.
The development leaves the Tempo scrambling for veteran leadership as training camp approaches. Meanwhile, fans and analysts are left wondering whether this failed medical will impact Mabrey’s market value across the league or open doors for other contending teams.
For now, the buzz in Toronto has shifted from excitement to cautious optimism as the young franchise navigates its first major roster setback.